NMPA Approval

Compound Sodium Chloride Injection

Approval Number

国药准字H20204045

Company河南利欣制药股份有限公司

Registration Date

October 12, 2020

Previous Approval Numbers

国药准字H20058527

Drug Information

Generic Name

复方氯化钠注射液

Dosage Form

注射剂

Strength

500ml

Drug Type

化学药品

Registration Date

October 12, 2020

Company Information

Applicant Company

Company Name河南利欣制药股份有限公司

Company Address

南阳市镇平工业园区

Manufacturing Company

Company Name河南利欣制药股份有限公司

Company Address

南阳市镇平工业园区

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

复方氯化钠注射液 - NMPA 批准文号 | MedPath